Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
310
Trial Sponsor
Clinical Trial Start Date
2009
0Primary Completion Date
2010
0Study Completion Date
2010
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Biological0
Interventional Trial Phase
Phase 40
Official Name
A Phase 4, Open-Label, Single-Group Immunogenicity and Safety Study of Re-exposure to RECOTHROM� (rThrombin) in Surgical Hemostasis0
Last Updated
December 8, 2011
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Other attributes
Intervention Treatment
rThrombin, 1000 IU/mL0
Study summary
The objective of this study is to assess the immunogenicity and safety of recombinant Thrombin (rThrombin) in patients with prior rThrombin exposure.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
